Neelam Panchal

Senior Commercialisation of Research Scientist, Cell and Gene Therapy Catapult

I am currently a Senior Scientist in the Commercialisation of Research (CoR) team at the cell and gene therapy Catapult (CGTC) where I support academics to develop more commercially investible opportunities. My role involves in-depth due diligence and project triaging to identify both scientific and commercial challenges and risks in order to devise mitigation strategies to advance the project.

Prior to my current role, I carried out my PhD and post-doctoral training and UCL Great Ormond Street Institute of Child Health where I gained extensive experience over the last decade in cell and gene therapy in the group of Professors Claire Booth, Bobby Gaspar, and Adrian Thrasher. I focused on developing novel therapeutic approaches using viral vector mediated gene transfer and gene editing to target and treat primary immunodeficiencies (PID).

Leonardo Royal Hotel London Tower Bridge

20 October 2022